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Potential interference of aluminum chlorohydrate with estrogen receptor 
signaling in breast cancer cells 
Introduction 
 
Aluminum is the most abundant metal and the third 
most widely used. Humans are exposed to aluminum 
compounds through diet, antacids, vaccines, and vari-
ous house hold products (Corain et al. 1990, Darbre et 
al. 2010). Moreover, application of Al-based antiper-
spirant to the underarm provides a high and continuous 
exposure to aluminum of an area located to the near 
proximity to the human breast. Aluminum salts in anti-
perspirants are soluble at very low pH. Moreover, alu-
minum ion absorption and bioavailability varies based 
on many factors such as the chemical form of alumi-
num and the integrity of the skin. (Bakir et al. 2015, 
Darbre et al. 2013, 2016). According to the opinion of 
the European Union Scientific Committee on Con-
sumer Safety (SCCS/1525/2014), due to the lack of 
adequate data on dermal penetration of aluminum, to 
estimate the internal dose of aluminum following cos-
metic uses, risk assessment cannot be performed. 
However, accumulating evidence indicate that the alu-
minum ion (Al+3) is toxic. Abnormally high levels of 
aluminum are related to pathological conditions such 
as dialysis dementa, iron-adequate microcytic anemia, 
osteomalacia, neurodegerative diseases, and breast 
cancer (Darbre et al. 2016, Dórea et al. 2015, Gherardi 
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Aluminum salts are widely used as the active antiper-
spirant in underarm cosmetic. Experimental observa-
tions indicate that its long term application may corre-
late with breast cancer development and progression. 
This action is proposed to be attributed, among others, 
to aluminum possible estrogen-like activities. In this 
study we showed that aluminum, in the form of alumi-
num chlorohydrate (ACH), caused increase in estrogen 
receptor alpha (ERα) protein levels, in ERα-positive 
MCF-7 cells. This effect was accompanied by moder-
ate activation of Estrogen Response Elements (ERE)-
driven reporter gene expression and 20%-50% increase 
in certain estrogen responsive, ERE-independent genes 
expression. Genes affected were ERα, p53, cyclin D1, 
and c-fos, crucial regulators of breast cancer develop-
ment and progression. ACH-induced genes expression 
was eliminated in the presence of the estrogen antago-
nist: ICI 182780, in MCF-7 cells, whereas it was not 
observed in ERα-negative MDA-MB-231 breast can-
cer cells, indicating aluminum interference with estro-
gen signaling. Moreover, ACH caused increase in the 
perinuclear localization of estrogen receptor alpha in 
MCF-7 breast cancer cells and increase in the mito-
chondrial Bcl-2 protein, possibly affecting receptors-
mediated mitochondrial actions and mitochondrial-
dependent apoptosis. ACH-induced perinuclear local-
ization of estrogen receptor beta was also observed in 
MDA-MB-231. Our findings indicate that aluminum 
actions on estrogen receptors protein level and subcel-
lular localization possibly affect receptors-mediated 
actions and thus, aluminum interference with estrogen 
signaling.  
Abstract 
et al. 2016, Maya et al. 2016, Mold et al. 2016). 
 As regards aluminum compounds implication 
to breast cancer development and progression, meas-
urements of aluminum in human breast tissue (Exley et 
al. 2007) and in nipple aspirate fluid (Mannello et al. 
2001) have shown higher levels of aluminum in tissue 
from women affected by breast cancer compared to the 
healthy ones (Darbre et al. 2009). Moreover, relative 
high levels of aluminum have been measured in the 
fluid collected from breast cysts observed in gross cys-
tic breast disease (Mannello et al. 2009), a benign 
breast disorder believed to facilitate the appearance of 
breast cancer. 
 In addition, experimental data show that alu-
minum chloride promotes anchorage independent 
growth in human mammary epithelial cells (Sappino et 
al. 2012). Moreover, long-term exposure to aluminum 
salts of oestrogen-responsive, MCF-7, as well as oes-
trogen unresponsive, MDA-MB-231, human breast 
cancer cells caused increase in their migratory proper-
ties (Bakir et al. 2015, Darbre et al. 2013, 2016). The 
metastatic properties of aluminum are attributed to alu-
minum-induced alterations to metalloproteinases levels 
and secretion (Bakir et al. 2015). 
 It is also proposed that aluminum act as a met-
alloestrogen. Dabre and colleagues (Darbre et al. 2006, 
2010) have shown that long exposure of MCF-7 cells 
to aluminum salts, such as aluminum chloride, (AlCl3) 
and aluminum chlorohydrate, [(Al2Cl(OH)5, ACH) at 
concentrations of 10-4 M, caused approximately two 
fold activation of estrogen response elements (HRE) 
driven reporter gene expression. Taking into account 
the crucial role of estrogens in breast physiology (Jia et 
al. 2015, Pasqualini et al. 2004), an involvement of 
aluminum in genomic and/or non-genomic estrogens 
actions via their cognate receptors, estrogen receptors 
(ERs) (Jia et al. 2015), may have great consequences 
in breast tissue pathophysiology. 
 The pathogenic mechanisms of aluminum un-
desired harmful effects are still under investigation. In 
this study the mechanisms of aluminum actions as a 
metalloestrogen and its possible implication in estro-
gen receptor related breast cancer development were 
further investigated.  
 
Materials and Methods 
 
Chemicals 
Dulbecco’s modified Eagle medium (DMEM), fetal 
bovine serum (FBS), MitoTracker Red CMXRos 
(CMX), and lipofectamin 2000 were obtained from 
Invitrogen. Molecular weight protein markers were 
from Fermentas, complete protease inhibitors cocktail 
were purchased from Roche. All other chemicals in-
cluding estradiol (E2) and ICI 182780 (ICI), and 
Hoechst 33342 were purchased from Sigma-Aldrich.  
 
Antibodies 
The ERβ-H150, ERα-G20 affinity purified polyclonal 
antibodies, and the α-tubulin monoclonal antibodies 
were provided by Santa Cruz Biotechnology. Mono-
clonal mouse antibodies against human β-actin (Sigma 
Aldrich), ERβ (Serotec), p53 (DAKO), and c-myc, Bcl
-2 (Cell Signalling) were also applied. 
 
Cell Culture 
MCF-7 and MDA-MB-231 breast cancer cells were 
maintained in DMEM, supplemented with 10 % FBS, 
2 mM glutamine, and penicillin/streptomycin. Growth 
medium for MCF-7 cells was also supplemented with 
1 μg/ml insulin and 10-10 E2. Cells were grown at 37oC 
in a humidified atmosphere with 5% CO2. 48-72 hrs 
before treatment, cells were cultured in phenol red free
-DMEM medium supplemented with 10% charcoal 
inactivated FBS, 1 μg/ml insulin, 2 mM glutamine, and 
penicillin/streptomycin. 
 
Immunofluorescence 
Cells grown on coverslips, in DMEM without phenol 
red supplemented with 10 % charcoal inactivated se-
rum, were incubated for 2 hr at 37 °C with 200 nM 
CMX, in the presence or absence of 10-9 M E2, 10-4 M 
ACH, alone or in combination as indicated, washed 
with phosphate buffer saline (PBS), fixed for 10 min at 
-20°C in methanol, transferred to acetone (-20°C) for 2 
min, and briefly air-dried.  Control cells were treated 
with vehicles (EtOH and ddH2O in the same dilution 
used for E2 and ACH). After three washings in PBST 
(0.1% Tween 20 in PBS), (5 min each), immunofluo-
resence was proceeded using primary ERs antibodies 
(final dilution of 1:50), appropriate secondary antibod-
ies conjugated with Alexa fluor 488, provided by Invi-
trogen, diluted 1/500 in PBST, and 1 μg/ml Hoechst 
33342 (Sigma-Aldrich). Specimens were mounted in 
polyvinyl alcohol-based anti-fading medium (Psarra et 
al. 2011). Cell specimens were observed with a Leica 
2000 DM microscope. Images were obtained with the 
optiMOS (Qimaging) camera. Quantification of the 
results was carried out by applying Image J analysis as 
previously described (McCloy et al. 2014). Briefly, an 
outline of area of interest was drawn; mean fluores-
cence was measured along with several adjacent back-
ground readings. The total corrected fluorescence of 
area of interest (TCF) = integrated density – (selected 
area x mean fluorescence of background readings), 
was calculated. This TCF was then equalized against 
the mean TCF of vehicle-treated cells. 60 cells were 
analyzed in each condition. Results presented as fold 
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increase over the fluorescence density of control cells. 
Statistical analysis (2-sided t-tests) was performed.  
      
Estrogen receptor transcriptional activity 
MCF-7 cells growing on 24-well plates, in hormone 
depleted medium, were co-transfected with an ERE 
promoter-driven luciferase construct (ER-Luc reporter 
gene construct) and a β-galactosidase reporter con-
struct using Lipofectamin 2000 according to manufac-
tures instructions. Cells were treated with 10-9 M E2 
and/or 10-4 M ACH for 6 hrs. Subsequently, cells were 
harvested, lysed in report lysis buffer (Promega), fol-
lowing the manufacturer’s protocol, and assayed for 
the expressed luciferase and β-galactosidase activities 
(Psarra et al. 2009). The light emission was measured 
using a chemiluminometer (LB 9508, Berthold) and 
adjusted to the β- galactosidase activity of the sample. 
Transfection efficiency was expressed as relative 
luciferase units (RLU). 
 
Crude mitochondrial isolation 
Crude mitochondrial fractions were isolated from 
MCF-7 cells by differential centrifugation (Psarra et 
al. 2005). Approximately 8x106 cells were allowed to 
grow for 48 h in phenol red free DMEM medium sup-
plemented with 10% charcoal inactivated fetal bovine 
serum and 1 μg/ml insulin, in 15 cm dishes. Cells were 
incubated for additional 72 hrs with 10-9 M E2 and/or 
10-4 M ACH, washed twice with ice-cold PBS, and 
harvested in 5 volumes of isotonic buffer (20 mM 
Hepes-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 
mM EDTA, 1 mM EGTA, 250 mM sucrose) in which 
protease inhibitors were added (1 mM dithiothreitol, 
0.1 mM phenylmethylsulfonyl fluoride and appropriate 
amount of protease inhibitors cocktail (Roche), accord-
ing to manufactures instructions). Cells were homoge-
nized at 4°C, with 20 strokes, using a glass Potter-
Elvejhem homogenizer, with a Teflon pestle. The ho-
mogenate (Total Extract, TE) was centrifuged for 5 
min, at 1000 X g. The supernatant was centrifuged at 
12,000 X g, for 20 min, to give the crude mitochon-
drial pellet. The crude mitochondrial pellet was 
washed twice with buffer B (0.21 M mannitol, 0.07 M 
sucrose, 5 mM Tris, 2.5 mM EDTA, 2.5 mM EGTA, 
pH 7.4), and centrifuged at 12,000 X g, for 10 min. 
The mitochondrial pellets were subsequently lysed in 
lysis buffer (20 mM Tris pH:7.5, 250 mM NaCl, 0.5 % 
Triton, 3 mM EDTA) supplemented with cocktail pro-
tease inhibitors and protein concentration was deter-
mined with the application of Bradford assay 
(Bradford et al. 1976).   
 
Electrophoresis and Western Blotting 
Cells grown on 6 well plate, for 48 h in phenol red free 
medium supplemented with 10 % charcoal inactivated 
fetal bovine serum, were incubated for additional 72 
hrs with 10-9 M E2, 10-4 M ACH, and 10-7 M ICI, a 
synthetic ER antagonist (Osborne et al. 2004), alone or 
in combination as indicated. Cells were washed in 
PBSX1, lysed in buffer A (20 mM Tris pH:7.5, 250 
mM NaCl, 0.5 % Triton, 3 mM EDTA) supplemented 
with cocktail protease inhibitors. After Bradford pro-
tein determination (Bradford et al. 1976), cell or sub-
cellular extracts were electrophoresed in discontinuous 
SDS-PAGE and Western blotted with specific antibod-
ies against ERα, ERβ, β-actin, α tubulin, p53, c myc, 
Bcl-2 as previously described (Psarra et al. 2011). β-
actin or α tubulin expression levels were evaluated for 
the normalization of ERs, p53, c-Myc, Bcl-2, expres-
sion levels. SDH was used for the normalization of the 
mitochondrial protein levels. Enhanced chemilumines-
cence was used for the detection of the protein bands. 
 
Real time PCR 
Cells grown on 6 well plate, for 48 h in phenol red free 
medium supplemented with 10% charcoal inactivated 
fetal bovine serum were further incubated for 2 or 6 
hrs in hormone free medium with 10-9 M E2 and/or   
10-4 M ACH and with 10-9 M E2 and/or 10-4 M ACH in 
combination with 10-7 M ICI. Subsequently, cells were 
washed with phosphate buffer saline and total RNA 
was extracted using Trizol followed by DNase treat-
ment (Promega) and reverse transcription into cDNA, 
using random primers and superscript II reverse tran-
scriptase (Invitrogen). Expressed levels of mRNA 
were quantified using real-time RCR which was per-
formed after mixing the cDNA with SYBR GreenER 
qPCR super mix Universal (Invitrogen) and appropri-
ate primers. Products were quantitated with the 
Mx30005P Real-Time System (Stratagene). Condi-
tions for PCR were: 52 °C for 2 min, 95 °C for 2 min, 
40 cycles of 95 °C for 15 s and 55 °C for 20 s, fol-
lowed by 72 °C for 20 s according to manufacturer 
suggestions. Primers for ERα p53, c-fos, cyclin D1, c-
Myc and β-actin are shown in Table 1. 
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  Forward Primer Reverse Primer 
ERα 
TGATCCTACCA-
GACCCTTCAGT 
CCAATCATCAG-
GATCTCTAGCC 
p53 
AGGAAATTTGCGT-
GTGGAGTAT 
TCCGTCCCAGTAGAT-
TACCACT 
CD1 
GTGGCCTCTAAGAT-
GAAGGAGA 
GCATTTTGGAGAG-
GAAGTGTTC 
c-Fos 
GCTTCAACGCAGAC-
TACGAG 
AGTGACCGTGGGAAT-
GAAGT 
GAPDH
  
CATGAGAAGTAT-
GACAACAGCCT 
AGTCCTTTCCACGA-
TACCAAAGT 
Table 1. Sequences of primers for RT-PCR. 
Statistical analysis 
All results are expressed as mean ± SD (n=3-6). Data 
were analysed by independent t-test or by analysis of 
variance followed by Tukey’s post-hoc test using 
SPSS software. Differences were considered signifi-
cant at a two tailed P value < 0.05. 
 
Results 
 
Effect of ACH on estrogen receptor alpha tran-
scriptional activation 
In this study, applying luciferase reporter gene assay, 
we examined whether estrogen receptor transcriptional 
activation is affected by relative short exposure (6 hrs) 
of MCF-7 cells to various concentrations of ACH (10-6 
M, 10-5 M, 10-4 M). As it is shown in Figure 1, increas-
ing concentrations of ACH, caused only moderate ER 
transcriptional activation, in ERα-positive MCF-7 
cells.  
 
Effect of ACH on the subcellular localization of 
ERα and ERβ in breast cancer cells 
Assessment of the effect of ACH and E2 on the sub-
cellular translocation of ERα and ERβ in MCF-7 cells 
and the subcellular translocation of ERβ in MDA-MB-
231 breast cancer cells, cultured in steroid free me-
dium, was achieved by applying immunofluoresence 
analysis, using commercially provided affinity purified 
antibodies against ERα and ERβ. As shown in Figure 
2C, 2E, 10-4 M ACH similarly to 10-9 M E2 caused 2.5 
to 3.5 fold increase in the perinuclear localization of 
ERβ in MDA-MB-231 cells. Ιn ERα-positive MCF-7 
cells, the nuclear localization of ERα was not signifi-
cantly affected either by E2 or ACH (Figure 2A, 2D), 
whereas 1.5 fold E2-induced increase in the perinu-
clear localization of ERβ was also observed (Figure 
2Β, 2E). ACH did not significantly altered ERα peri-
nuclear localization in MCF-7 cells (Figure 2A, 2D).  
 
Effect of ACH on ERα protein levels 
Based on previous observations showing transcrip-
tional regulation of ERα by 10-4M ACH in MCF-7 
cells (Darbre et al. 2005) and taking into account our 
results showing moderate ER transcriptional activa-
tion, upon exposure of MCF-7 cells to 10-5M or 10-4M 
ACH, for a relative short period of time, ACH effect 
on ERα protein levels was examined by applying 
Western blot analysis of protein extracts from MCF-7 
cells, treated with 10-9 M E2, 10-4 M ACH, or 10-7 ICI 
alone or in combination with E2 or ACH, for 4 days. 
As it is shown in Figure 3A,B, ACH caused increase in 
ERα protein levels, whereas E2 caused moderate re-
duction in ERα protein levels. In the presence of ICI, 
alone or in combination with either E2 or ACH, ERα 
protein levels were decreased.  
 
Effect of ACH on ERα and estrogen responsive 
genes expression  
In order to explore whether the observed increase in 
ERα protein levels and the moderate increase in ERα 
transcriptional activation, upon relative short exposure 
of MCF-7 cells to ACH, is accompanied with altera-
tions in ERα and ERE-independent estrogen respon-
sive genes expression, mRNA levels of ERα, and ERα 
target genes such as c-myc, c- fos, cyclin D1 and p53 
(Björnström et al. 2005, Bondesson et al. 2015) were 
examined upon 2h or 6h incubation of MCF-7 cells 
with E2 (10-9 M), ACH (10-4 M), or ICI (10-7 M) alone 
or in combination of them as indicated (Figure 4). As 
shown in Figure 4A, upon 2h incubation of MCF-7 
cells, E2 caused approximately  2.5 and 3.5 fold, in-
crease in the mRNA levels of cyclin D1 and, c-fos re-
spectively, compared to control, untreated cells. Simi-
larly, ACH caused approximately 1.5 fold increase in 
the mRNA levels of c-fos and cyclin D1 compared to 
control cells. Interestingly, these effects were dimin-
ished in cells incubated either with E2 or ACH in com-
bination with ICI, the well-known ERα antagonist 
(Osborne et al. 2004). Moreover, in the presence of E2 
in combination with ACH an increase in the mRNA 
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Figure 1. Effect of ACH on ERE-driven luciferase gene 
expression in MCF-7 cells. ERα positive MCF-7 cells cul-
tured in hormone depleted medium were transiently co-
transfected with an ER-Luc reporter gene construct, and a β-
galactosidase reporter construct. Cells were further incu-
bated for 48 hrs and subsequently treated with the indicated 
concentrations of ACH, and/or 10-9M E2 (diluted in EtOH) 
for 6 hrs. Control cells were treated with an equal volume of 
ddH2O and EtOH (1:1000). Cells were lysed and activity of 
luciferase and β-galactosidase was measured in cell extracts. 
Luciferase activity was normalized against β-galactosidase 
activity and expressed as relative luciferase unit. Data are 
expressed as mean ± S.D. (n=6), *P<0.05. 
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Figure 2. ACH induced perinuclear 
localization of ERα and ERβ in breast 
cancer cells. MCF-7 (A,B) and MDA-
MB-231 (C) cells cultured in hormone 
depleted medium for 48 hrs were in-
cubated with 10-4M ACH or 10-9M E2 
in DMEM hormone free medium sup-
plemented with 200 nM CMX. Con-
trol cells were treated with ddH20 and 
EtOH at the same dilution as treated 
cells. Following 2 hrs incubation, cells 
were washed in PBS and fixed in 
methanol-acetone. For immunochem-
istry analysis antibodies against ERβ 
(ERβ-H150) (B,C), ERα (ΕRα-G20) 
(A) and anti-rabbit secondary antibod-
ies Alexa Fluor® 488 conjugated 
(Green) were applied. Hoechst 33342 
(Blue) dye for nuclear staining was 
also used. Representative images were 
presented. Bars indicate 50 μm. ERα 
nuclear and perinuclear-mitochondrial 
localization in MCF-7 cells (D) and 
ERβ perinuclear-mitochondrial local-
ization (E) in E2- or ACH- treated 
cells is expressed as relative fluores-
cence density compared to control 
cells. Data are expressed as mean ± 
S.D. (n= 60), *P<0.05, ***P<0.001, 
compared to controls. 
levels of c-fos, ERα and p53, compared to control and 
E2- or ACH- treated cells, was observed, upon two 
(Figure 4A) or six hours treatment of the cells (Figure 
4B). Evaluation of the effect of ACH and E2 on ERα, 
p53 and cyclin D1 gene expression, in ERα-negative 
MDA-MB-231 cells showed no ACH effect on the 
respective mRNA synthesis (Figure 4C), indicating 
that the effect of ACH on ERα, p53, and cyclin D1 
gene expression is possible, at least in part, ERα-
mediated. As regards assessments of c-myc gene ex-
pression in MCF-7 cells, we found that E2, upon 2h 
and 6h incubation, caused 14.6 ± 2.2 and 2.5 ± 0.1 fold 
increase, respectively, in c-myc gene expression com-
pared to the respective control cells, whereas ACH did 
not alter c-myc expression (data not shown). 
 Evaluation of the ACH effect on protein levels 
of the ACH-affected estrogen targets showed that E2 
caused increase in p53 and c-myc protein synthesis 
compared to control cells, whereas in the presence of 
ICI, the E2- induced increase in p53 and c-myc protein 
level was eliminated, verifying the involvement of es-
trogen receptor in this process (Figure 5A). ACH 
caused moderate increase in p53 protein synthesis, 
whereas it had no effect on c-myc protein synthesis, 
compared to control cells, which is in accordance with 
the ACH effect on c-myc mRNA levels. The involve-
ment of ERα in ACH-induced increase in p53 protein 
level was also verified in ERα negative MDA-MB-231 
cells, since no remarkable ACH-induced increase in 
p53 protein level was observed (Figure 5B). In addi-
tion no significant ACH-induced effect on ERβ protein 
level was observed in MCF-7 and MDA-MB-231 
breast cancer cells (Figure 5). Moreover, an antagonis-
tic effect of ACH on E2-induced ERβ protein synthesis 
was observed in MCF-7 cells treated with ACH in 
combination with E2 (Figure 5A). 
 
Effect of ACH on mitochondrial related actions 
Taking into account the known perinuclear localization 
of mitochondria in many type of cells (Okatsu et al. 
2010) and the ACH-induced increase in the perinuclear 
localization of estrogen receptors, we attempted to 
evaluate the effect of ACH on mitochondrial localiza-
tion of certain estrogen responsive regulatory mole-
cules. Thus, evaluation of the ACH-induced mitochon-
drial localization of ERα, p53 and Bcl2 was performed 
in total as well as in mitochondrial extracts from MCF-
7 cells, treated or not with ACH or E2 (Figure 6). Tu-
bulin was used for the assessment of the mitochondrial 
purity and the normalization of protein levels from 
total extracts. Protein levels of succinate dehydro-
genase (SDH), a tricarboxylic acids cycle enzyme and 
a protein component of the mitochondrial inner mem-
brane was analyzed for the normalization of mitochon-
drial protein levels. As it is shown in Figure 6, the pro-
tein levels of Bcl2 were increased by ACH in mito-
chondrial as well as in total cell extracts. In addition 
the ACH induced mitochondrial localization of ERα, 
observed by immunofluoresence and western blot 
analysis, was also confirmed. The presence of SDH 
and the absence of α-tubulin from mitochondrial ex-
tracts verified the mitochondrial enrichment and the 
absence of cytosolic contamination from mitochondrial 
fractions.    
6  Journal of Molecular Biochemistry, 2018 
Figure 3. ACH induced increase in ERα protein levels in MCF-7 cells. Evaluation of ACH effect on ERα protein levels was 
achieved by Western blot analysis of ERα, and β-actin protein levels, in total extracts from ERα positive MCF-7 breast cancer 
cells, treated with 10-4M ACH, 10-9M E2, 10-7M ICI and in combination of them, as indicated, in hormone depleted medium, 
for 4 days. Commercially provided antibodies were used. B. Normalization of protein levels against β-actin protein levels. Re-
sults are expressed as mean ± SD (n=3), *P <0.05, ***P<0.001. 
Discussion 
 
Estrogens are steroid hormones that regulate, cell 
growth, differentiation, metabolism and function of 
many target tissues in the human body. Estrogens me-
diate their actions through estrogen receptor alpha and 
beta, which belong to the large superfamily of nuclear 
receptors and regulate the expression of a large number 
of genes via genomic and non-genomic mechanisms of 
actions (Björnström et al. 2005, Bondesson et al. 
2015). Genomic actions involve direct or indirect 
DNA binding. The classical pathway includes direct 
binding of estrogen receptors to estrogen response ele-
ments, upon ligand activation, and transcriptional 
regulation of genes carrying ERE at their correspond-
ing promoters, whereas the ERE-independent genomic 
actions includes protein-protein interactions with other 
transcription factors and transcriptional regulation of 
their target genes. Estrogens non-genomic, rapid ef-
fect, are proposed to be exerted through ligand depend-
ent activation of membrane receptors or ligand-
independent pathways involving cytosolic ERs phos-
phorylation and activation (Heldring et al. 2007). 
 Estrogens play crucial role in mammary gland 
morphogenesis and breast cancer progression (Jia et al. 
2015). It is widely accepted that ERα promotes tumori-
genesis and cancer progression in breast tissues. On 
the contrary, ERβ is proposed to inhibit breast cancer 
cell proliferation via repression of the activation of 
MAPK and PI3K signaling pathways, inhibition of 
ERα activity, and regulation of genes controlling cell 
cycle progression and apoptosis (Chang et al. 2006, 
Cotrim et al. 2013). 
 Many environmental factors, natural or syn-
thetic chemicals known as xenoestrogen interfere with 
estrogen receptor signaling and act as endocrine dis-
ruptors (Acconcia et al. 2016). Endocrine disruptors 
interact with the synthesis, secretion, transport, me-
tabolism, binding, action, and elimination of natural 
hormones (Marino et al. 2012). The measured Kd of 
many xenoestrogens toward ERα and ERβ is in the 
micromolar range. Despite the 10,000-fold lower affin-
ity xenoestrogens have for ERs, compared to E2 (Kd= 
1 nM), xenoestrogens interfere with E2 signaling 
through ERα and ERβ receptor (Acconcia et al. 2016).  
Some metals, known as metalloestrogens, are also 
known to elicit estrogen-like activity (Byrne et al. 
2013). Among them, aluminum, at concentration of 10-
5M - 10-4M, is proposed to act as a metalloestrogen and 
its implication in breast cancer formation, development 
and progression is explored (Darbre et al. 2005, 2006, 
2013, 2016). Although aluminum salts solubility is low 
at neutral pH, and its dermal absorption varies between 
0.1%-2%, the aluminum concentration detected in 
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Figure 4. Effect of ACH on mRNA synthesis of estrogen 
responsive molecules. Real-time PCR was applied to deter-
mine the mRNA levels of ERα, p53, Cyclin D1 (CD1), c-
Fos, and β-actin in MCF-7 (A,B) and MDA-MB-231 cells 
(C), upon 2h (A) and 6 hr (B,C) incubation of the cells with 
10-9M E2, 10-4M ACH, or 10-7M ICI alone or in combina-
tion of them, as indicated, in hormone depleted medium. β-
actin was used as a reference gene. The results of three inde-
pendent experiments as means ± S.D. are shown. Vertical 
aligned asterisks indicate statistical significance differences 
compared to control vehicle treated cells. *P <0.05, 
**P<0.01, ***P<0.001, when compared with the respective 
cells, as indicated.  
breast cyst fluids and nipple aspirate fluid from breast 
cancer patients varies between 1 μΜ-10 μΜ (Manello 
et al. 2009, 2011). 
 In an effort to further investigate the possible 
estrogenic activity of the aluminum ion (Al+3) and to 
delineate the molecular mechanisms underlining this 
action, the effect of aluminum, in the form of alumi-
num chlorohydrate (ACH) on the subcellular translo-
cation of estrogen receptor alpha and beta in ERα posi-
tive MCF-7 and the subcellular translocation of estro-
gen receptor beta in ERα negative MDA-MB-231 
cells, was examined. In addition the estrogenic activity 
of ACH as regards ΕRs protein levels regulation, and 
transcriptional regulation of -ERE-driven reporter gene 
and -ERE-independent target genes expression was 
evaluated. 
 Our results show that relative short exposure 
(4 hrs) of ERα positive MCF-7 breast cancer cells to 
ACH at concentration range from 10-6M to 10-4M 
caused only moderate activation of an ERE driven re-
porter gene transcription. The discrepancy between our 
results and those from earlier studies, showing ap-
proximately two fold transcriptional activation of es-
trogen receptor, upon 8 days, exposure of MCF-7 cells 
to aluminum salts (Darbre et al. 2005, 2006), may be 
attributed to the different incubation period applied. 
 Similar to the moderate effect of ACH on ER 
transcriptional activation, and in accordance with pre-
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Figure 5. ACH effect on protein synthesis of estrogen responsive molecules in MCF-7 and MDA-MB-231 cells. Western blot 
analysis of ERβ, p53, c-myc, and β-actin protein levels was performed in total extracts from MCF-7 (A) and MDA-MB-231 
(B) human breast cancer cells treated with 10-4M ACH, 10-9M E2, 10-7M ICI and in combination of them, in hormone depleted 
medium, for 4 days. Commercially provided antibodies were used. β-actin protein levels was used for the normalization of the 
results. Quantification of the results in MCF-7 (C) and MDA-MB-231 (D) are expressed as mean ± S.D. (n=3), *P <0.05, 
**P<0.01, when compared with the respective control cells, as indicated. 
vious findings (Darbre et al. 2005), evaluation of the 
estrogenic activity of ACH in MCF-7 cells prolifera-
tion, upon 5 days exposure of MCF-7 cells to alumi-
num chlorohydrate, revealed no statistically significant 
ACH-induced activation of cell proliferation (data not 
shown). 
 Since no remarkable ACH effect on estrogen 
direct genomic actions was observed, we focused on 
the elucidation of the possible ACH involvement in 
ERE-independent, estrogen-indirect genomic actions 
and on ERα protein level regulation. Interestingly, 
upon 4 days incubation of MCF-7 cells, with 10-4 M 
ACH, ERα protein levels were increased by 2-3 fold 
compared to control cells. The molecular mechanism 
of the ACH-induced increase in ERα protein level 
could be attributed, at least in part, to aluminum estro-
genic activity since this effect is abolished in the pres-
ence of the ER antagonist ICI 182780, which is also 
known to cause ERα protein degradation and reduction 
(Jaber et al. 2006, Johnston et al. 2010, Osborne et al. 
2004). In accordance with previous findings (Pinzone 
et al. 2004, Saceda et al. 1988) we showed that 10-9M 
E2 induced approximately 20% reduction in ERα pro-
tein levels in MCF-7 cells. This action is proposed to 
be attributed either to the direct binding of the ERα-Ε2 
complex to the estrogen response elements (ERE) of 
the promoter region of ERα (Pinzone et al. 2004) or to 
the induction of ERα protein degradation (reviewed by 
Acconcia et al. 2016). Interestingly in the presence of 
ACH, the E2 effect on ERα protein level was attenu-
ated, indicating a possible interference of aluminum 
with estrogen signaling via an antagonistic effect of 
ACH on the E2-induced ERα protein level regulation.    
In order to examine whether the ACH action on ERα 
protein level is relied on the activation of estrogen re-
ceptor gene expression, the effect of E2 and ACH on 
ERα mRNA synthesis was evaluated. In accordance 
with previous findings (reviewed by Pinzone et al. 
2004), 6 hours exposure of MCF-7 cells to 10-9M E2 
caused two fold induction in the ERα mRNA synthe-
sis. As regards ACH effect on ERα mRNA synthesis, 
almost 10% induction was observed. Differential effect 
on ERα mRNA and protein levels has also been ob-
served in the case of other xenoestrogens such as the 
Nar xenoestrogen (La Rosa et al. 2014). Nevertheless, 
this effect may also indicate that aluminum has a 
strong influence on estrogen receptor protein stability. 
The biochemical mechanism(s) of the regulation of 
ERα protein stability by ACH needs to be further ex-
plored, but it possibly involves ACH-induced confor-
mational changes in ERα molecule, or ACH-induced 
ERα post-translational modifications rendering ERα 
less susceptible to proteolysis (Kawahara et al. 2011, 
Tecalco-Cruz et al. 2017). ER posttranslational modi-
fication affected by ACH could be phosphorylation, 
palmytoylation, acetylation, sumoylation and or lysine 
or arginine methylation, events modifying estrogen 
receptor expression and stability, subcellular localiza-
tion, and sensitivity to hormonal response (Le Ro-
mancer et al. 2011). 
 The ACH-induced increase in ERα protein 
level may have consequences in the regulation of 
EREs-dependent or EREs-independent estrogen-
responsive genes expression, among them, genes that 
encode the synthesis of crucial regulators of breast 
cancer development and progression. Accordingly, our 
results indicate that ACH may affects the expression of 
p53, p21, cyclin D1, and c-fos genes. 
 More specifically, expression of p53, which is 
an ERα target gene (Berger et al. 2012), via associa-
tion of ERα with Sp1 at the GC-rich motif in the proxi-
mal p53 promoter (Gu et al. 2012), was increased in 
MCF-7 cells, treated for 2 or 6 hrs with ACH in com-
bination with E2, compared to control cells. The addi-
tive effect of ACH and E2 on p53 mRNA synthesis 
possibly indicates estrogen-like activity of ACH. This 
action could be attributed either to a direct ACH effect 
on ERα genomic actions or to an indirect effect, result-
ing from the ACH-induced increase in ER protein 
level. Increase in estrogen receptor protein level may 
lead to increase in p53 protein level but also suppres-
sion of its anti-tumor activity. This assumption is 
based on observations showing direct interaction of 
ERα with p53 (Liu et al. 2006, 2009, Sayeed et al. 
2007), which leads to ERα dependent inhibition of p53 
transcriptional activity, and thus suppression of p53-
responsive anti-proliferative and apoptotic genes ex-
pression (Berger et al. 2012, Gu et al. 2012, Liu et al. 
2009, 2016, Sayeed et al. 2007). The ERα involvement 
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Figure 6. ACH-induced increase in mitochondrial related 
molecules. Western blot analysis of Bcl-2, ERα, p53, SDH 
and α-tubulin, in total and crude mitochondrial extracts from 
ACH- or E2- treated MCF-7 cells, using commercially pro-
vided antibodies, is presented. SDH and α-tubulin were 
used, for the normalization of mitochondrial and total ex-
tract protein levels, respectively.  
in the ACH-induced increase in p53 level is also sup-
ported by the inability of ACH to affect p53 gene ex-
pression in ERα negative MDA-MB-231 breast cancer 
cells. Increase in p53 protein level is also proposed to 
be associated with induction of cellular senescence 
(Qian et al. 2013). Recently, induction of cellular se-
nescence and up regulation of the p53/p21Waf1 pathway 
by aluminum, in the form of AlCl3, possibly via an 
ERα independent manner, has also been demonstrated 
by Sappino et al (Sappino et al. 2012). 
 Other genes that contain GC-rich promoter 
sequences and constitute ERs target via ERs interac-
tion with the Sp1 transcription factor (Porter et al. 
1997) are those of c-fos (Duan et al. 1998) and cyclin 
D1 (Castro-Rivera et al. 2001). In this study the E2-
induced expression of c-fos and cyclin D1 gene ex-
pression was verified. Although to a lower compared 
to E2 extent, ACH caused increase in both genes ex-
pression. In addition, the additive effect of E2 and 
ACH on c-fos and cyclin D1 gene expression, upon 
two and six hours incubation of MCF-7 cells, respec-
tively, and the elimination of the ACH effect on both 
genes expression in the presence of ICI, further sup-
port the notion of a possible estrogenic activity of 
ACH. The ACH-induced effect on cyclin D1 gene ex-
pression may be, at least in part, ERα-mediated since 
this action was abolished in ERα negative MDA-MB-
231 cells. Taking into account that p53, cyclin D1 and 
c-fos are important regulators in carcinogenesis and 
breast cancer progression (Sana et al. 2015), their in-
duction by ACH could possibly contribute to cancer 
development. 
 In contrast to the effect of ACH on ERα, p53, 
c-fos and cyclin D1 expression, no ACH effect on c-
myc gene expression was observed. On the other hand, 
consistent with previous observations, E2 induced c-
myc gene expression (Chen et al. 2015, Wang et al. 
2011). It is possibly indicated that the ERα conforma-
tional changes and/or post-translational modifications, 
such us phosphorylation, palmitoylation, sumoylation 
and/or ER methylation, potentially affected by ACH, 
may differentially favor binding and requirement of 
certain components of the multi-protein dynamic tran-
scription complex leading to differential regulation of 
ER target genes expression and ERs subcellular target-
ing. 
 ERs subcellular localization was also affected 
by aluminum chlorohydrate. ACH similarly to E2, 
caused remarkable increase in the perinuclear translo-
cation of ERβ, in both types of breast cancer cells. 
Based on previous findings showing mitochondrial 
localization of ERβ, (Chen et al. 2004, Liao et al. 
2015, Psarra et al. 2008) as well as perinuclear accu-
mulation of mitochondria (Al-Mehdi et al. 2012, Lon-
ergan et al. 2007, Okatsu et al. 2010), our observations 
may indicate an increase in the mitochondrial localiza-
tion of ERβ by ACH. Mitochondrial estrogen receptor 
beta is proposed to favor mitochondrial biogenesis, 
bioenergetics and anti-apoptotic signaling (Chen et al. 
2004, 2009, Levin et al. 2009). In addition, increased 
oxidative mitochondrial metabolism is associated with 
increased tumor growth in human epithelial breast can-
cer cells, providing them with the necessary energy 
fuels and precursors molecules to cover their energy 
and proliferative demands (Al-Mehdi et al. 2012, Mar-
tinez-Outschoorn et al. 2011). Thus, increase in the 
mitochondrial localization of ERβ by ACH may favor 
breast cancer formation. In the same context, ACH-
induced increase in the mitochondrial antiapoptotic 
Bcl2 molecule, that constitute an estrogen target gene 
(Perillo et al. 2000), may support mitochondrial viabil-
ity and anti-apoptotic actions, leading to the observed 
ACH-induced cellular senescence (Childs et al. 2014, 
Raffetto et al. 2001, Sappino et al. 2012). 
 To conclude our results show that aluminum 
salts induce a remarkable increase in estrogen receptor 
protein level possibly via interference with estrogen 
receptor gene expression or estrogen receptor protein 
stability. This effect may have consequences in breast 
physiology, affecting estrogen receptor mediated gene 
expression via direct or indirect estrogen receptor 
DNA binding. Genes affected were genes of p53, cy-
clin D1, cfos, crucial regulators of breast cancer devel-
opment and progression and/or cellular senescence. 
Although the ACH – induced increase in the above 
mentioned ERα target genes took place to a moderate 
degree, the ACH effect on ERα protein level or stabil-
ity could cause sustainable increase in ERα target gene 
expression and attenuation of the regulatory feedback 
mechanism of estrogen on ERα-mediated estrogen re-
sponse. In addition, aluminum via induction of perinu-
clear localization of estrogen receptors might affect 
mitochondrial physiology and function to provide can-
cer cells with the necessary energy production and sup-
ply of precursor molecules. Our findings do not pro-
vide conclusive evidence that aluminum is a breast 
carcinogen. However, the daily exposure to aluminum 
in connection with its possible role as an endocrine 
disruptor raises concerns about the safety of its use. 
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